Alkermes plc.

Ownership Transactions Reported by 23 Insiders

Symbol
ALKS on Nasdaq
Industry
Pharmaceutical Preparations
Location
Connaught House, 1 Burlington Road, Dublin 4, Ireland

Insiders trading volume in the past year

Alkermes plc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard F. Pops Director and CEO, Alkermes plc, Director $38.9M Feb 26, 2024
Michael J. Landine SVP, Corp Dev., Alkermes, Inc. $10.1M Feb 23, 2024
Blair C. Jackson EVP, Chief Operating Officer $8.28M Feb 23, 2024
David Joseph Gaffin EVP, CLO, Alkermes, Inc. $7.58M Aug 3, 2024
Iain M. Brown SVP, Chief Financial Officer $5.88M Feb 23, 2024
Craig C. Hopkinson EVP R&D, Chief Medical Officer $4.51M -$4.78M -51.4% Dec 9, 2024
Christian Todd Nichols SVP, Chief Commercial Officer $4.12M -$445K -9.74% Nov 27, 2024
David Angelo Daglio Jr. Director $3.13M Jun 29, 2024
Shane Cooke Director $2.95M Jun 29, 2024
David W. Anstice Director $2.2M Jun 14, 2022
Brian P. Mckeon Director $1.45M Jun 29, 2024
Wendy L. Dixon Director $1.37M Jun 14, 2022
Cato T. Laurencin Director $1.27M -$171K -11.9% Dec 8, 2024
Nancy Wysenski Director $1.21M Jul 7, 2023
Emily Peterson Alva Director $1.2M Jun 29, 2024
nancy lynn snyderman MD Director $1.15M Jun 29, 2024
Frank Anders Wilson Director $1.14M Jun 29, 2024
Richard Gaynor Director $1.14M Jun 29, 2024
Christopher I. Wright Director $885K Jun 29, 2024
Samuel Joseph Parisi VP, Finance (Interim PAO) $789K -$75.9K -8.77% Feb 23, 2024
Nancy Lurker Director $537K May 31, 2024
Paul J. Mitchell Director $470K May 20, 2021
Robert A. Breyer Director $267K May 20, 2021

Recent Insider Transactions by Companies or Individuals for Alkermes plc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.